Amyloid-β Peptides Interact with Plasma Proteins and Erythrocytes: Implications for Their Quantitation in Plasma

Kuo, Yu-Min, Kokjohn, Tyler A., Kalback, Walter, Luehrs, Dean, Galasko, Douglas R., Chevallier, Nathalie, Koo, Edward H., Emmerling, Mark R. +1 more·2000·Biochemical and Biophysical Research Communications
DOI 10.1006/bbrc.2000.2222

Cited by (230)

Items 101–200 of 230

  1. Reduced levels of IgM autoantibodies against N-truncated pyroglutamate Aβ in plasma of patients with Alzheimer's disease
    Andrea Marcello, Oliver Wirths, Thomas Schneider-Axmann, Malin Degerman-Gunnarsson, Lars Lannfelt, Thomas A. Bayer · 2009 · Neurobiology of Aging
  2. Advance in Plasma AD Core Biomarker Development: Current Findings from Immunomagnetic Reduction-Based SQUID Technology
    Lih‐Fen Lue, Yu‐Min Kuo, Marwan Noel Sabbagh · 2019 · Neurology and Therapy
  3. The binding of Aβ1–42 to lipid rafts of RBC is enhanced by dietary docosahexaenoic acid in rats: Implicates to Alzheimer's disease
    Michio Hashimoto, Shahdat Hossain, Masanori Katakura, Abdullah Al Mamun, Osamu Shido · 2015 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  4. Fatty Acids Compete with Aβ in Binding to Serum Albumin by Quenching Its Conformational Flexibility
    Cong Guo, Huan‐Xiang Zhou · 2018 · Biophysical Journal
  5. Elevation of plasma soluble amyloid precursor protein beta in Alzheimer’s disease
    Sang‐Moon Yun, Sun-Jung Cho, Chulman Jo, Moon Ho Park, Changsu Han, Young Ho Koh · 2019 · Archives of Gerontology and Geriatrics
  6. Crosslinked zwitterionic polymeric ionic liquid-functionalized nitinol wires for fiber-in-tube solid-phase microextraction and UHPLC-MS/MS as an amyloid beta peptide binding protein assay in biological fluids
    Israel Donizéti de Souza, Jared L. Anderson, Maria Eugênia Costa Queiroz · 2021 · Analytica Chimica Acta
  7. Longitudinal Neuroimaging Analysis in Mild-Moderate Alzheimer’s Disease Patients Treated with Plasma Exchange with 5% Human Albumin
    Gemma Cuberas‐Borrós, Isabel Roca, Merçé Boada, Lluís Tárraga, Isabel Hernández, Mar Buendía, Lourdes Rubio, Gustavo Torres, A. Bittini, Juan A. Guzmán‐De‐Villoria et al. · 2017 · Journal of Alzheimer s Disease
  8. Characterisation of adducts of the lipid peroxidation product 4‐hydroxy‐2‐nonenal and amyloid β‐peptides by liquid chromatography/electrospray ionisation mass spectrometry
    Fulvio Magni, Chiara Galbusera, Laura Tremolada, Carlo Ferrarese, Marzia Galli Kienle · 2002 · Rapid Communications in Mass Spectrometry
  9. Soluble Amyloid-β . Levels and Late-Life Depression
    Ricardo S. Osorio, Tyler Gumb, Nunzio Pomara · 2014 · Current Pharmaceutical Design
  10. Heart and Brain: Complex Relationships for Left Ventricular Dysfunction
    Gianlorenzo Daniele, Stephanie DiLucia, Pier Giorgio Masci, Federica del Monte · 2020 · Current Cardiology Reports
  11. Solid-phase extraction enhances detection of beta-amyloid peptides in plasma and enables Aβ quantification following passive immunization with Aβ antibodies
    Thomas A. Lanz, Joel B. Schachter · 2007 · Journal of Neuroscience Methods
  12. Circulating immune complexes of Aβ and IgM in plasma of patients with Alzheimer’s disease
    Andrea Marcello, Oliver Wirths, Thomas Schneider-Axmann, Malin Degerman-Gunnarsson, Lars Lannfelt, Thomas A. Bayer · 2009 · Journal of Neural Transmission
  13. New frontiers in Alzheimer's disease diagnostic: Monoamines and their derivatives in biological fluids
    Alessandra Gallo, Laure‐Elise Pillet, Romain Verpillot · 2021 · Experimental Gerontology
  14. Increased Cerebrospinal Fluid Aβ38/Aβ42 Ratio in Alzheimer Disease
    Pankaj D Mehta, Tuula Pirttilä · 2005 · Neurodegenerative Diseases
  15. Hemoglobin binding to Aβ and HBG2 SNP association suggest a role in Alzheimer's disease
    Rodney T. Perry, Debra A. Gearhart, Howard W. Wiener, Lindy E. Harrell, James C. Barton, Abdullah Kutlar, F. Kutlar, Ozan Ozcan, Rodney C.P. Go, William Hill · 2006 · Neurobiology of Aging
  16. The Amyloid‐β Peptide in Amyloid Formation Processes: Interactions with Blood Proteins and Naturally Occurring Metal Ions
    Cecilia Wallin, Jinghui Luo, Jüri Jarvet, Sebastian K.T.S. Wärmländer, Astrid Gräslund · 2016 · Israel Journal of Chemistry
  17. Identifying the role of co-aggregation of Alzheimer’s amyloid-β with amorphous protein aggregates of non-amyloid proteins
    Jinming Wu, Nicklas Österlund, Hongzhi Wang, Rebecca Sternke‐Hoffmann, Hegne Pupart, Leopold L. Ilag, Astrid Gräslund, Jinghui Luo · 2022 · Cell Reports Physical Science
  18. Detection of Soluble Amyloid‐β Oligomers and Insoluble High‐Molecular‐Weight Particles in CSF: Development of Methods with Potential for Diagnosis and Therapy Monitoring of Alzheimer′s Disease
    Susanne Aileen Funke · 2011 · International Journal of Alzheimer s Disease
  19. Neuronal nicotinic acetylcholine receptors serve as sensitive targets that mediate ?-amyloid neurotoxicity
    Qiang Liu, Jie Wu · 2006 · Acta Pharmacologica Sinica
  20. Aβ, aging, and Alzheimer's disease: A tale, models, and hypotheses
    Michael O. Chaney, Jerome Y. Baudry, Chera L. Esh, Jennifer Childress, Dean C. Luehrs, Tyler A. Kokjohn, Alex E. Roher · 2003 · Neurological Research
  21. Pathology of Amyloid-β (Aβ) Peptide Peripheral Clearance in Alzheimer’s Disease
    Andrey Tsoy, Bauyrzhan A. Umbayev, Aliya Kassenova, Bibifatima Kaupbayeva, Sholpan Askarova · 2024 · International Journal of Molecular Sciences
  22. Human Plasma Protein Corona of Aβ Amyloid and Its Impact on IAPP Cross-Seeding
    Aparna Nandakumar, Yanting Xing, Ritchlynn Aranha, Ava Faridi, Aleksandr Kakinen, I. Javed, Kairi Koppel, Emily H. Pilkington, A. Purcell, T. Davis et al. · 2020 · Biomacromolecules
  23. Albumin protects human red blood cells against A??25???35-induced lysis more effectively than ApoE
    Luciano Galeazzi, Roberta Galeazzi, Maria Beatrice Valli, Elizabeth H. Corder, Sergio Giunta · 2002 · Neuroreport
  24. Advances in sample preparation and HPLC–MS/MS methods for determining amyloid-β peptide in biological samples: a review
    Israel Donizéti de Souza, Maria Eugênia Costa Queiroz · 2023 · Analytical and Bioanalytical Chemistry
  25. Definition of a Threshold for the Plasma Aβ42/Aβ40 Ratio Measured by Single-Molecule Array to Predict the Amyloid Status of Individuals without Dementia
    Lise Colmant, Emilien Boyer, Thomas Gérard, Kristel Sleegers, Renaud Lhommel, Adrian Ivanoiu, Philippe Lefèvre, Pascal Kienlen‐Campard, Bernard Jimmy Hanseeuw · 2024 · International Journal of Molecular Sciences
  26. Characterizing Aging, Mild Cognitive Impairment, and Dementia with Blood-Based Biomarkers and Neuropsychology
    Martin Kleinschmidt, Robby Schoenfeld, Claudia Göttlich, Daniel Bittner, Jürgen Erich Metzner, Bernd Leplow, Hans‐Ulrich Demuth · 2016 · Journal of Alzheimer s Disease
  27. Amyloid Beta Peptide Is Released during Thrombosis in the Skin
    Lilia Y. Kucheryavykh, Yuriy V. Kucheryavykh, Anthony Valance Washington, Mikhail Y. Inyushin · 2018 · International Journal of Molecular Sciences
  28. Interactions of intrinsically disordered proteins with the unconventional chaperone human serum albumin: From mechanisms of amyloid inhibition to therapeutic opportunities
    Karla Martinez Pomier, Rashik Ahmed, Giuseppe Melacini · 2021 · Biophysical Chemistry
  29. A Method for the Detection of Amyloid-β1-40, Amyloid-β1-42 and Amyloid-β Oligomers in Blood Using Magnetic Beads in Combination with Flow Cytometry and its Application in the Diagnostics of Alzheimer's Disease
    Alexander Navarrete Santos, Andreas Simm, Vjera Holthoff‐Detto, Gerald Boehm · 2008 · Journal of Alzheimer s Disease
  30. Several Direct and Calculated Biomarkers from the Amyloid-β Pool in Blood are Associated with an Increased Likelihood of Suffering from Mild Cognitive Impairment
    Virginia Pérez‐Grijalba, Pedro Pesini, Inmaculada Monleón, Merçé Boada, Lluís Tárraga, Agustı́n Ruiz, Pablo Martínez‐Lage, Itziar San José, Manuel Sarasa · 2013 · Journal of Alzheimer s Disease
  31. Plasma β-amyloid (Aβ) 40 concentration, lipid status and age in humans
    Christopher Smith, D. J. Betteridge · 2004 · Neuroscience Letters
  32. Unaltered Plasma Levels of β-Amyloid(1–40) and β-Amyloid(1–42) upon Stimulation of Human Platelets
    Annika Olsson, Eugeen Vanmechelen, Hugo Vanderstichele, Pia Davidsson, Kaj Blennow · 2003 · Dementia and Geriatric Cognitive Disorders
  33. Rapid Detection of Protein Aggregation and Inhibition by Dual Functions of Gold Nanoplasmonic Particles: Catalytic Activator and Optical Reporter
    Inhee Choi, Elizabeth Lee, Minsun Song, Luke P. Lee · 2014 · Biophysical Journal
  34. Differential Roles of Plasma Protein Corona on Immune Cell Association and Cytokine Secretion of Oligomeric and Fibrillar Beta-Amyloid
    Ava Faridi, Wen Li Yang, Hannah G. Kelly, Chuanyu Wang, Pouya Faridi, Anthony Wayne Purcell, Thomas Paul Davis, Pengyu Chen, Stephen John Kent, Pu Chun Ke · 2019 · Biomacromolecules
  35. Alzheimer's Disease Diagnosis Using Misfolding Proteins in Blood
    HeeYang Lee, Daniella A. Ugay, Seungpyo Hong, Young Soo Kim · 2020 · Dementia and Neurocognitive Disorders
  36. Oxidative Stress Boosts the Uptake of Cerium Oxide Nanoparticles by Changing Brain Endothelium Microvilli Pattern
    Roberta Dal Magro, Agostina Vitali, Stefano Fagioli, Alberto Casu, Andrea Falqui, Beatrice Formicola, Lorenzo Taiarol, Valeria Cassina, Claudia Adriana Marrano, Francesco Mantegazza et al. · 2021 · Antioxidants
  37. Efficacy and Safety of Cilostazol in Mild Cognitive Impairment
    Satoshi Saitô, Keisuke Suzuki, Ryo Ohtani, Takakuni Maki, Hisatomo Kowa, Hisatsugu Tachibana, Kazuo Washida, Nobuya Kawabata, Toshiki Mizuno, Rie Kanki et al. · 2023 · JAMA Network Open
  38. Alteration of protein kinase C conformation in red blood cells: A potential marker for Alzheimer's disease but not for Parkinson's disease
    Agnes K. Janoshazi, François Sellal, Christian Marescaux, Jean‐Marie Danion, Jean‐Marie Warter, Jennifer Debarry · 2005 · Neurobiology of Aging
  39. Carbon Nanostructure-Based Materials: A Novel Tool for Detection of Alzheimer’s Disease
    Mohammad Ashfaq, Neetu Talreja, Divya Chuahan, Werayut Srituravanich · 2019 · Springer eBooks
  40. Multipronged Regulatory Functions of Serum Albumin in Early Stages of Amyloid-β Aggregation
    Mengjuan Zhao, Cong Guo · 2021 · ACS Chemical Neuroscience
  41. Association of Plasma β-Amyloid with Cognitive Performance and Decline in Chronic Kidney Disease
    Janine Gronewold, Olga Todica, Hans‐Wolfgang Klafki, Ulla K. Seidel, Britta Kaltwasser, Jens Wiltfang, Andreas Kribben, Heike Bruck, Dirk Matthias Hermann · 2016 · Molecular Neurobiology
  42. Amyloid solutions: lecanemab, gantenerumab, and donanemab in the treatment of Alzheimer's disease
    Taha Basit Ameen, Umair Ali, Omme Salma, Muhammad Abdul Samee, Syed Muhammad Iraj Abbas, Syeda Naveera Kashif, Muhammad Arif Arifi, Mashooque Ali, Maher Khowaja, Syed Muhammad Sinaan Ali et al. · 2025 · The Egyptian Journal of Neurology Psychiatry and Neurosurgery
  43. Red cell interactions with amyloid-β1–40 fibrils in a murine model
    Luke B. Ravi, Suresh Poosala, Dongchoon Ahn, Francis J. Chrest, Edward L. Spangler, Jayakumar Rajadas, Enika Nagababu, Joy G. Mohanty, Mark I. Talan, Donald K. Ingram et al. · 2005 · Neurobiology of Disease
  44. Therapeutic plasma exchange with albumin: a new approach to treat Alzheimer’s disease
    Merçé Boada, Pablo Martínez‐Lage, Pedro Jesús Serrano-Castro, Montserrat Costa, Antonio Páez · 2021 · Expert Review of Neurotherapeutics
  45. High-performance liquid chromatography coupled with tandem mass spectrometry for the detection of amyloid Beta peptide related with Alzheimer's disease.
    Chengan Du, Corinne Ramaley, Hugh James McLean, Susan C. Leonard, Jeff Miller · 2005 · PubMed Central
  46. Association of MTHFR and PICALM polymorphisms with Alzheimer’s disease
    Luciano Belcavello, Daniela Camporez, Leila D. Almeida, Renato Lírio Morelato, Maria C. P. Batitucci, Flavia Paula · 2014 · Molecular Biology Reports
  47. A new methodology for simultaneous quantification of total-Aβ, Aβx-38, Aβx-40, and Aβx-42 by column-switching LC/MS/MS
    Kenichi Watanabe, Chihiro Ishikawa, Hiroshi Kuwahara, Kimihiko Sato, Setsuko Komuro, Tetsuya Nakagawa, Naruaki Nomura, Shiro Watanabe, Masashi Yabuki · 2011 · Analytical and Bioanalytical Chemistry
  48. Amyloid insulin interaction with erythrocytes
    J Murali, D Koteeswari, Joseph Moses Rifkind, Jayakumar Rajadas · 2003 · Biochemistry and Cell Biology
  49. Creutzfeldt-Jakob, Parkinson, Lewy Body Dementia and Alzheimer Diseases: From Diagnosis to Therapy
    Ingrid Dupiereux-Fettweis, Willy Zorzi, Isabelle Quadrio, Armand Perret‐Liaudet, Gábor Géza Kovács, Ernst Heinen, Benaïssa Elmoualij · 2009 · Central Nervous System Agents in Medicinal Chemistry
  50. A systematic review of amyloid-β peptides as putative mediators of the association between affective disorders and Alzheimer׳s disease
    Leda Abbasowa, Niels H. H. Heegaard · 2014 · Journal of Affective Disorders
  51. A gold nanoparticle-mediated rapid in vitro assay of anti-aggregation reagents for amyloid β and its validation
    Hye Young Kim, Donghee Lee, Kwon‐Yul Ryu, Inhee Choi · 2017 · Chemical Communications
  52. The Sun Health Research Institute Brain Donation Program: description and experience, 1987–2007
    Thomas G. Beach, Lucia I. Sue, Douglas G. Walker, Alex E. Roher, Lih‐Fen Lue, Linda J. Vedders, Donald J. Connor, Marwan Noel Sabbagh, Joseph Rogers · 2007 · Cell and Tissue Banking
  53. Plasma Exchange Reduces Aβ Levels in Plasma and Decreases Amyloid Plaques in the Brain in a Mouse Model of Alzheimer’s Disease
    Santiago Ramírez, Suélyn Koerich, Natalia Astudillo, Nicole De Gregorio, Rabab Al‐Lahham, Tyler Allison, Natália Pessoa Rocha, Fei Wang, Claudio A. Soto · 2023 · International Journal of Molecular Sciences
  54. Blood-based quantification of Aβ oligomers indicates impaired clearance from brain in ApoE ε4 positive subjects
    Lara Blömeke, Fabian Rehn, Marlene Pils, Victoria Kraemer‐Schulien, Anneliese Cousin, Janine Kutzsche, Tuyen Bujnicki, Silka Dawn Freiesleben, Luisa‐Sophie Schneider, Lukas Preis et al. · 2024 · Communications Medicine
  55. Endogenous Aβ peptide promote Aβ oligomerization tendency of spiked synthetic Aβ in Alzheimer's disease plasma
    Young Ki Choi, Yechan Joh, Ji Sun Ryu, Kaylen Kim, David Seo, SangYun Kim · 2021 · Molecular and Cellular Neuroscience
  56. Neuroimaging analyses from a randomized, controlled study to evaluate plasma exchange with albumin replacement in mild-to-moderate Alzheimer’s disease: additional results from the AMBAR study
    Gemma Cuberas‐Borrós, Isabel Roca, Joan Castell‐Conesa, Laura Núñez, Merçé Boada, Oscar L. López, Carlota Grifols, Miquel Barceló, Deborah Pareto, Antonio Páez · 2022 · European Journal of Nuclear Medicine and Molecular Imaging
  57. Distribution of Aβ peptide in whole blood
    J. Randall Slemmon, Cory L. Painter, Sashi Nadanaciva, Florentina Catana, Ashley Cook, Ruth N. Motter, Peter A. Seubert · 2006 · Journal of Chromatography B
  58. Biological Markers for Alzheimer's Disease
    Tero Tapiola · 2001
  59. Plasma Exchange in Alzheimer's Disease
    Lucas Rohrer, Muharrem Yünce, Thomas Jude Montine, Hua Shan · 2022 · Transfusion Medicine Reviews
  60. Albumin domain mutants with enhanced Aβ binding capacity identified by phage display analysis for application in various peripheral Aβ elimination approaches of Alzheimer's disease treatment
    Yu Ishima, Ai Mimono, Victor Tuan Giam Chuang, Tetsuya Fukuda, Kohshi Kusumoto, Keiichiro Okuhira, Yoshiaki Suwa, Hiroshi Watanabe, Tatsuhiro Ishida, Hiroshi Morioka et al. · 2019 · IUBMB Life
  61. Comparative studies for amyloid beta degradation: “Neprilysin vs insulysin”, “monomeric vs aggregate”, and “whole Aβ40 vs its peptide fragments”
    Dai Kato, Yoshiaki Takahashi, Haruto Iwata, Yusuke Hatakawa, Seon Hwa Lee, Tomoyuki Oe · 2022 · Biochemistry and Biophysics Reports
  62. Red Blood Cells’ Thermodynamic Behavior in Neurodegenerative Pathologies and Aging
    Svetla J. Todinova, Sashka Krumova, Desislava Bogdanova, Avgustina Danailova, Elena Zlatareva, Nikolay Kalaydzhiev, Ariana Langari, Ivan Gospodinov Milanov, Stefka Germanova Taneva · 2021 · Biomolecules
  63. Feasibility, safety, and tolerability of two modalities of plasma exchange with albumin replacement to treat elderly patients with Alzheimer's disease in the AMBAR study
    Merçé Boada, DOBRI D. KIPROV, Fernando Anaya, Oscar L. López, Laura Núñez, Javier Olazarán, José Lima, Carlota Grifols, Miquel Barceló, Regina Rohe et al. · 2022 · Journal of Clinical Apheresis
  64. Toxicity of serum albumin on microglia upon seeding effect of amyloid peptide
    Maryam Ferdousi, Mehran Habibi-Rezaei, Saeed Balalaie, Sorour Ramezanpour, Farzaneh Sabouni, Najmeh Poursasan, Manijeh Sabokdast, Ali Akbar Moosavi‐Movahedi · 2016 · The Journal of Biochemistry
  65. The Role of Amyloid-β, Tau, and α-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid Angiopathy
    Rebecca Piccarducci, Maria Chiara Caselli, Elisa Zappelli, Leonardo Ulivi, Simona Daniele, Gabriele Siciliano, Roberto Ceravolo, Michelangelo Mancuso, Filippo Baldacci, Claudia Martini · 2022 · Journal of Alzheimer s Disease
  66. Development and Implementation of an Internal Quality Control Sample to Standardize Oligomer-Based Diagnostics of Alzheimer’s Disease
    Marlene Pils, Alexandra Dybala, Fabian Rehn, Lara Blömeke, Tuyen Bujnicki, Victoria Kraemer‐Schulien, Wolfgang Hoyer, Detlev Riesner, Dieter Willbold, Oliver Bannach · 2023 · Diagnostics
  67. In Search for Low-Molecular-Weight Ligands of Human Serum Albumin That Affect Its Affinity for Monomeric Amyloid β Peptide
    Evgenia I. Deryusheva, Marina P. Shevelyova, Victoria A. Rastrygina, Немашкалова Екатерина Леонидовна, Вологжанникова Алиса Андреевна, Мачулин Андрей Валериевич, Aliya A. Nazipova, Maria E. Permyakova, Sergei E. Permyakov, Литус Екатерина Андреевна · 2024 · International Journal of Molecular Sciences
  68. Role of glycolysis and antioxidant enzymes in the toxicity of amyloid beta peptide Aβ25–35 to erythrocytes
    Elena A. Kosenko, Ilya Solomadin, N. V. Marov, Natalya I. Venediktova, A. S. Poghosyan, Yu. G. Kaminsky · 2008 · Russian Journal of Bioorganic Chemistry
  69. Monitoring the amyloid beta-peptide in vivo – caveat emptor
    Paul W. Thompson, Andrew Lockhart · 2009 · Drug Discovery Today
  70. Reduction of AHI1 in the serum of Taiwanese with probable Alzheimer’s disease
    Jau‐Jiuan Sheu, Li‐Yu Yang, Monika Renuka Sanotra, Sen‐Te Wang, Hsien‐Tsung Lu, Rachel Sook Yee Kam, I-Uen Yvonne Hsu, Shu‐Huei Kao, Ching‐Kuo Lee, Jonathan Chang-Cheng Shieh et al. · 2019 · Clinical Biochemistry
  71. Efficient extraction of intact HSA-Aβ peptide complexes from sera: Toward albuminome biomarker identification
    Emilie Rossi, Nguyet Thuy Tran, Christophe Hirtz, Sylvain Lehmann, Myriam Taverna · 2020 · Talanta
  72. Different Sides of Depression in the Elderly: An In-depth View on the Role of Aβ Peptides
    Giovanni Pagni, Claudia Tagliarini, Manuel Glauco Carbone, Bruno Pietro Imbimbo, Donatella Marazziti, Nunzio Pomara · 2021 · Current Medicinal Chemistry
  73. Diagnostic biologique de la maladie d’Alzheimer : avancées, limites et perspectives
    Catherine Malaplate, Cédric Desbène, Thierry Pillot, J L Olivier · 2008 · Revue Neurologique
  74. Modulation of neutrophil apoptosis by β-amyloid proteins
    Hae‐Young Park, Joo‐In Park, Dae-Won Baek, Sun‐Young Lee, Min-Jung Lee, Jun‐O Jin, Ja‐Woong Kim, Young‐Seoub Hong, Yong-Hwan Lee, Jong‐Young Kwak · 2006 · International Immunopharmacology
  75. Increased activity of Piezo1 channel in red blood cells is associated with Alzheimer's disease‐related dementia
    Valeriia Sitnikova, Dilyara Nurkhametova, Nicoletta Braidotti, Catalin Dacian Ciubotaru, Luca Giudice, Ulla Impola, Sari Kärkkäinen, Juho Kalapudas, Elina Penttilä, Heikki Löppönen et al. · 2025 · Alzheimer s & Dementia
  76. Analysis of Differentially Expressed Genes Associated With Alzheimer’s Disease Based on Bioinformatics Methods
    Bo Feng, Peng Hu, Jinbo Chen, Qingxin Liu, Xizhi Li, Yifeng Du · 2014 · American Journal of Alzheimer s Disease & Other Dementias®
  77. On-chip plasmonic immunoassay based on targeted assembly of gold nanoplasmonic particles
    Hyo Sil Kim, Sang Hun Lee, Inhee Choi · 2019 · The Analyst
  78. Panel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer's Disease
    Suk Ling Ma, LINDA C. W. LAM · 2011 · Clinical Psychopharmacology and Neuroscience
  79. Polyphenol-Peptide Interactions in Mitigation of Alzheimer’s Disease: Role of Biosurface-Induced Aggregation
    Roger Gaudreault, Vincent Hervé, Theo G. M. van de Ven, Normand Mousseau, Charles Ramassamy · 2021 · Journal of Alzheimer s Disease
  80. Amyloid capture and aggregation inhibition by human serum albumin
    Diego Cora, Wajih Al‐Soufi, Mercedes Novo · 2025 · International Journal of Biological Macromolecules
  81. Reference Intervals for Plasma Amyloid β in Korean Adults Without Cognitive Impairment
    Min Young Kim, Kyu-Nam Kim, Hyemin Cho, Duck-Joo Lee, Doo‐Yeoun Cho · 2016 · Annals of Laboratory Medicine
  82. Albumin as a natural and moldable biomaterial for biomimetic drug delivery applications
    Ankit Rochani, Vivek S. Dave, Miriam Hernandez Meadows, Aditya Bajaj, Quezia Lacerda, Tala Alzien, Sara Woytowicz, John Eisenbrey, Todd D. Camenisch, Gagan Kaushal · 2025 · International Journal of Pharmaceutics
  83. Characterization of the molecular composition and in vitro regenerative capacity of platelet-based bioproducts and related subfractions
    Andrea Acebes‐Huerta, Patricia Martínez-Botía, Graciela Carbajo-Argüelles, Judit Fernández Fuertes, María Carmen Muñoz‐Turrillas, Ana María Ojea-Pérez, Antonio López‐Vázquez, Johannes Andreas Eble, Laura Gutiérrez · 2024 · Acta Biomaterialia
  84. Role of Human Serum Albumin in the Prevention and Treatment of Alzheimer’s Disease
    Marina P. Shevelyova, Evgenia I. Deryusheva, Немашкалова Екатерина Леонидовна, Мачулин Андрей Валериевич, Литус Екатерина Андреевна · 2024 · Biology Bulletin Reviews
  85. Covalent immobilization of human serum albumin on cellulose acetate membrane for scavenging amyloid beta – A stepping extracorporeal strategy for ameliorating Alzheimer’s disease
    Aziz Ullah, Gyu-Jin Lee, Hyuk Taek Kwon, Sung In Lim · 2024 · Colloids and Surfaces B Biointerfaces
  86. Molecular dynamics of amyloid-β transport in Alzheimer's disease: Exploring therapeutic plasma exchange with albumin replacement – Current insights and future perspectives
    R. Mondal, Shramana Deb, Gourav Shome, Vramanti Sarkar, Durjoy Lahiri, S.S. Datta, Julián Benito‐León · 2024 · Neurología
  87. Toxic effect of Aβ25–35 and fullerene C60 on erythrocytes
    Ilya Solomadin, N. V. Marov, Natalya I. Venediktova, Elena A. Kosenko, Yu. G. Kaminsky · 2008 · Biology Bulletin
  88. Albumin: A Multi-talented Clinical and Pharmaceutical Player
    Aziz Ullah, Hyuk Taek Kwon, Sung In Lim · 2022 · Biotechnology and Bioprocess Engineering
  89. Follow-up Comparisons of Two Plasma Biomarkers of Alzheimer’s Disease, Neurofilament Light Chain, and Oligomeric Aβ: A Pilot Study
    YongSoo Shim · 2023 · Current Alzheimer Research
  90. Qualification and application of a liquid chromatography–tandem mass spectrometric method for the determination of human Aβ1-40 and Aβ1-42 peptides in transgenic mouse plasma using micro-elution solid phase extraction
    Y. Shin, L. Hamm, S. Murakami, Kenji Buirst, M. Buonarati, April A Cox, K. Regal, Kevin W. Hunt, K. Scearce-Levie, R. Watts et al. · 2013 · Archives of pharmacal research
  91. A multipronged, nutritional-based strategy for managing Alzheimer’s disease
    J. Leslie Glick, Philip A. McMillan · 2016 · Medical Hypotheses
  92. Rapid and high-throughput colorimetric screening for anti-aggregation reagents of protein conformational diseases by using gold nanoplasmonic particles
    Hye Young Kim, Jung Ah Kwon, Taewook Kang, Inhee Choi · 2017 · Nanomedicine Nanotechnology Biology and Medicine
  93. Modifiable risk factors promoting neurodegeneration is associated with two novel brain degradation markers measured in serum
    Jesper Skov Neergaard, Katrine Dragsbæk, Claus Christiansen, Henning Bay Nielsen, Christopher Thomas Workman, Susanne Brix, Kim Henriksen, M.A. Karsdal · 2017 · Neurochemistry International
  94. A Surface-Engineered Microfluidic Platform with Algorithmic Optimization for Plasma Biomarker Detection in Alzheimer’s Disease
    Yue Cheng, Limoran Tang, Tan Yi, Hongpan Xu, Dan Yang, Zhixin Zhou, Wenqian Gao, Zhihong Ke, Chenglu Mao, Zheqi Hu et al. · 2025 · ACS Sensors
  95. N-terminal truncation of peptide effects on human serum albumin and beta amyloid peptide interaction
    Malihe Sarvari Zare, Mohammad Reza Bozorgmehr, Sharareh Mohseni, S. Ali Beyramabadi · 2023 · Journal of the Indian Chemical Society
  96. Aluminum enhances the toxic effects of amyloid β-peptide on cell membranes and a molecular model
    Mario Suwalsky, Pedro Hernández · 2011 · Monatshefte für Chemie - Chemical Monthly
  97. Modulating Role of TTR in Aβ Toxicity, from Health to Disease
    Isabel Cardoso, Luís Miguel Santos, Mobina Alemi · 2016 · InTech eBooks
  98. Measuring Amyloid‐β Peptide Concentrations in Murine Brain with Improved ELISA Assay
    Hao Peng, Inés A.M. de Lannoy, K. Sandy Pang · 2021 · Current Protocols
  99. Multifunctional Effects of Human Serum Albumin Toward Neuroprotection in Alzheimer Disease
    Assaf Ezra, Inna Rabinovich-Nikitin, Polina Rabinovich‐Toidman, Beka Solomon · 2017 · Elsevier eBooks
  100. Amyloid β Peptide Modifies Membrane Architecture and Surface Electrostatic Properties of Human Red Blood Cells
    Galya Staneva, Vesela Yordanova, Avgustina Danailova, Ana-Mariya Marinovska, András Dér, Stefka Germanova Taneva · 2025 · International Journal of Molecular Sciences